Insurers Tracking Unnecessary Testing with Myriad's BRACAnalysis Tests

Data from two national insurers, Humana and Aetna, shows that around 20 percent of requests for the test do not meet requirements for testing under their policy. A United Healthcare official has cited competitors' data suggesting that as much as 80 percent of requests for Myriad's BRCA test are withdrawn after pre-certification and genetic counseling procedures are conducted.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.